DiscoverBladder Cancer Matters
Bladder Cancer Matters
Claim Ownership

Bladder Cancer Matters

Author: Bladder Cancer Advocacy Network

Subscribed: 28Played: 407
Share

Description

Bladder Cancer Matters is the podcast for, by and about the bladder cancer community. Host Rick Bangs interviews interesting guests from the bladder cancer community, including patients, survivors, advocates, medical professionals, researchers, caregivers and more. It is brought to you by the Bladder Cancer Advocacy Network.
135 Episodes
Reverse
What if a new approach to gene therapy could give people with bladder cancer more treatment options while making treatment easier to manage? In this episode of Bladder Cancer Matters, host Rick Bangs welcomes Anthony Cheung, co-founder of enGene Therapeutics, to explore an innovative investigational treatment for patients with high-risk non-muscle invasive bladder cancer who no longer respond to BCG therapy. Discover how enGene is using non-viral gene delivery technology to help the body's immune system recognize and attack bladder cancer cells. Cheung shares the surprising conversation that inspired enGene's entry into bladder cancer research, explains how its investigational therapy works and discusses promising directions in ongoing clinical trials. You'll also hear why making treatments more convenient, accessible and less burdensome for patients is central to the company's mission. For patients, caregivers and anyone interested in the future of bladder cancer treatment, this conversation offers a fascinating look at the science behind potential new treatment options.
Can patients with muscle-invasive bladder cancer safely keep their bladders after successful treatment? And does having "no evidence of disease" really mean the cancer is gone? In this episode of Bladder Cancer Matters, host and bladder cancer survivor Rick Bangs welcomes back renowned bladder cancer expert Dr. Ashish Kamat of MD Anderson Cancer Center to explore one of the most important decisions patients may face: bladder removal or bladder preservation. Dr. Kamat explains how newer treatments are improving survival, what doctors can—and cannot—determine about whether cancer remains and the potential risks and benefits of preserving the bladder. He also discusses why ongoing monitoring is essential and what patients should ask their medical teams before making treatment decisions. If you or someone you love is facing bladder cancer treatment, this conversation offers valuable insights to help you understand your options and make informed decisions.
Bladder cancer treatment can change much more than a person's physical health — it can profoundly affect sexuality, intimacy, body image and relationships. In this candid and informative episode of Bladder Cancer Matters, host and bladder cancer survivor Rick Bangs talks with Mary Dunn, a certified adult nurse practitioner about a topic patients and partners may find difficult to discuss: sex after bladder cancer.  Mary explains how bladder cancer and its treatments can affect sexual health for both men and women, offers practical strategies for managing common challenges and reviews treatment options that can help. Just as importantly, she explores intimacy beyond sex and encourages patients to make sexual health part of the conversation with their healthcare teams. Listener discretion advised: This episode contains explicit language and frank discussions of sexual health, sexual function and anatomy that may not be appropriate for all listeners.
In this eye-opening episode of Bladder Cancer Matters, brought to you by the Bladder Cancer Advocacy Network, host Rick Bangs sits down with Todd Davey of Ferring Pharmaceuticals to pull back the curtain on something most patients never hear about: market access. What actually happens between a breakthrough therapy and the moment a patient can affordably receive it? Todd walks listeners through the strategy, value demonstration, and launch planning that determine whether innovative bladder cancer treatments—like ADSTILADRIN®—are covered by insurance and accessible without crushing out-of-pocket costs. It's a candid, behind-the-scenes look at how science, economics, and patient advocacy intersect—and why getting this right can mean fewer barriers, less financial stress, and more options for families facing bladder cancer. If you've ever wondered how new treatments move from the lab to real life, this episode will give you clarity—and a new appreciation for the complex work that helps turn innovation into access.
For women facing radical cystectomy, removing the bladder doesn't always have to mean removing reproductive organs as well. In this episode of Bladder Cancer Matters, host Rick Bangs talks with Cleveland Clinic urologic oncologist Dr. Rebecca Campbell about organ-sparing radical cystectomy and how, for carefully selected patients, surgeons may be able to preserve the vagina, uterus and ovaries while still prioritizing effective cancer treatment. Dr. Campbell explains who may be a candidate, how organ sparing can help protect sexual function, hormonal health, continence and overall quality of life and why women should feel empowered to ask their surgeon about their options—or seek a second opinion if those options aren't discussed. It's an important conversation about looking beyond bladder removal to the life a patient wants to live after treatment.
loading
Comments